日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Artificial intelligence as a ploy to delve into the intricate link between genetics and mitochondria in patients with MASLD

利用人工智能技术深入探究MASLD患者遗传学与线粒体之间错综复杂的联系。

Longo, Miriam; Paolini, Erika; Meroni, Marica; Ripolone, Michela; Napoli, Laura; Gentile, Francesco; Cespiati, Annalisa; Trombetta, Elena; Lombardi, Rosa; Maggioni, Marco; Alisi, Anna; Miele, Luca; Liguori, Antonio; Soardo, Giorgio; Gasbarrini, Antonio; Moggio, Maurizio; Fracanzani, Anna Ludovica; Dongiovanni, Paola

What Not to Overlook in the Management of Patients with Type 2 Diabetes Mellitus: The Nephrological and Hepatological Perspectives

2型糖尿病患者管理中不容忽视的方面:肾脏病学和肝脏病学的视角

Alfieri, Carlo Maria; Molinari, Paolo; Cinque, Felice; Vettoretti, Simone; Cespiati, Annalisa; Bignamini, Daniela; Nardelli, Luca; Fracanzani, Anna Ludovica; Castellano, Giuseppe; Lombardi, Rosa

Nutritional and Lifestyle Therapy for NAFLD in People with HIV

针对艾滋病毒感染者非酒精性脂肪性肝病的营养和生活方式疗法

Cinque, Felice; Cespiati, Annalisa; Lombardi, Rosa; Guaraldi, Giovanni; Sebastiani, Giada

The I148M PNPLA3 variant mitigates niacin beneficial effects: How the genetic screening in non-alcoholic fatty liver disease patients gains value

I148M PNPLA3 变体减轻了烟酸的有益作用:非酒精性脂肪肝患者的基因筛查如何获得价值

Erika Paolini, Miriam Longo, Marica Meroni, Giada Tria, Annalisa Cespiati, Rosa Lombardi, Sara Badiali, Marco Maggioni, Anna Ludovica Fracanzani, Paola Dongiovanni

An Overview of Hepatocellular Carcinoma Surveillance Focusing on Non-Cirrhotic NAFLD Patients: A Challenge for Physicians

肝细胞癌监测概述——以非肝硬化性NAFLD患者为例:对医生的挑战

Cespiati, Annalisa; Cinque, Felice; Meroni, Marica; Lombardi, Rosa; Dongiovanni, Paola; Fracanzani, Anna Ludovica

Impact of Sarcopenia and Myosteatosis in Non-Cirrhotic Stages of Liver Diseases: Similarities and Differences across Aetiologies and Possible Therapeutic Strategies

肌少症和肌脂肪变性对非肝硬化期肝病的影响:不同病因的异同及可能的治疗策略

Cespiati, Annalisa; Meroni, Marica; Lombardi, Rosa; Oberti, Giovanna; Dongiovanni, Paola; Fracanzani, Anna Ludovica

Usefulness of fibrosis-4 (FIB-4) score and metabolic alterations in the prediction of SARS-CoV-2 severity

纤维化-4 (FIB-4) 评分和代谢改变在预测 SARS-CoV-2 严重程度中的应用价值

Lombardi, Rosa; Mura, Vincenzo La; Cespiati, Annalisa; Iuculano, Federica; Sigon, Giordano; Pallini, Giada; Proietti, Marco; Motta, Irene; Montinaro, Beatrice; Fiorelli, Elisa; Cesari, Matteo; Bandera, Alessandra; Valenti, Luca; Peyvandi, Flora; Montano, Nicola; Baldini, Marina; Fracanzani, Anna Ludovica

Correction to: Usefulness of Fibrosis-4 (FIB-4) score and metabolic alterations in the prediction of SARS-CoV-2 severity

更正:纤维化-4 (FIB-4) 评分和代谢改变在预测 SARS-CoV-2 严重程度中的应用价值

Lombardi, Rosa; La Mura, Vincenzo; Cespiati, Annalisa; Iuculano, Federica; Sigon, Giordano; Pallini, Giada; Proietti, Marco; Motta, Irene; Montinaro, Beatrice; Fiorelli, Elisa; Cesari, Matteo; Bandera, Alessandra; Valenti, Luca; Peyvandi, Flora; Montano, Nicola; Baldini, Marina; Fracanzani, Anna Ludovica

PCSK7 gene variation bridges atherogenic dyslipidemia with hepatic inflammation in NAFLD patients

PCSK7基因变异将动脉粥样硬化性血脂异常与非酒精性脂肪性肝病患者的肝脏炎症联系起来

Dongiovanni, Paola; Meroni, Marica; Baselli, Guido; Mancina, Rosellina M; Ruscica, Massimiliano; Longo, Miriam; Rametta, Raffaela; Cespiati, Annalisa; Pelusi, Serena; Ferri, Nicola; Ranzani, Valeria; Nobili, Valerio; Pihlajamaki, Jussi; Fracanzani, Anna Ludovica; Badiali, Sara; Petta, Salvatore; Fargion, Silvia; Romeo, Stefano; Kozlitina, Julia; Valenti, Luca

Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver

非酒精性脂肪肝中肝脏脂肪与肝损伤和胰岛素抵抗的因果关系

Dongiovanni, P; Stender, S; Pietrelli, A; Mancina, R M; Cespiati, A; Petta, S; Pelusi, S; Pingitore, P; Badiali, S; Maggioni, M; Mannisto, V; Grimaudo, S; Pipitone, R M; Pihlajamaki, J; Craxi, A; Taube, M; Carlsson, L M S; Fargion, S; Romeo, S; Kozlitina, J; Valenti, L